Drug Industry | featured news

As drug industry’s influence over research grows, so does the potential for bias

Drug Industry

For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup. The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.

 

Big Pharma Wins Big With Health Care Reform Bill

Big Pharma Wins Big With Health Care Reform Bill

Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage.

 

Subscribe to this RSS topic: Syndicate content